Published in Zh Mikrobiol Epidemiol Immunobiol on June 01, 1989
Preliminary results of Cytos 2 experiment. Acta Astronaut (1985) 0.82
A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB. Acta Naturae (2011) 0.78
A novel plasmid-mediated DNA restriction-modification system in E. coli. Plasmid (1980) 0.78
[Exotoxin A production during Pseudomonas aeruginosa PA-7 cultivation in Martin's broth]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.76
[Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613]. Antibiotiki (1968) 0.75
[Protective action of a corpuscular polyvalent Pseudomonas aeruginosa vaccine against representative enterobacteria]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Selective media for isolating Pseudomonas aeruginosa]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Protective artificial polysaccharide-protein antigens made from the O-specific polysaccharides of Pseudomonas aeruginosa bacteria of the immunotypes 1, 2 and 7]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Chemotherapy of experimental lactational mastitis in mice]. Antibiotiki (1978) 0.75
[Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics]. Zh Mikrobiol Epidemiol Immunobiol (1987) 0.75
[Antibiotic resistance of hospital strains of Pseudomonas aeruginosa in resuscitation and intensive therapy units]. Antibiot Med Biotekhnol (1985) 0.75
[Pseudomonas aeruginosa slime: chemical composition and biological characteristics]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Suppresion of the R-factor transduction transmission of antibiotic resistance markers in E. coli by distamycin A]. Antibiotiki (1975) 0.75
[Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A]. Dokl Akad Nauk SSSR (1988) 0.75
[Changes of Escherichia coli ultrastructure by treatment with antibiotics of penicillin group and 6-aminopenicillanic acid]. Mikrobiologiia (1969) 0.75
[Antibacterial activity of a number of preparations and their combination with a proteolytic enzyme against the microflora of burn and surgical wounds]. Antibiot Med Biotekhnol (1986) 0.75
[Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75
[The epidemiological markers of Pseudomonas aeruginosa strains circulating in different types of hospitals]. Zh Mikrobiol Epidemiol Immunobiol (1996) 0.75
[Treatment of endophthalmitis with a single intravitreous administration of cefotaxime and gentamicin in an experiment]. Antibiot Khimioter (1991) 0.75
[The diagnostic effectiveness of erythrocyte immunoreagents made from different Pseudomonas aeruginosa antigens]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Erythrocyte diagnostic kits for detection of Pseudomonas aeruginosa exotoxin A]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75
[Serotypes of Pseudomonas aeruginosa strains isolated in obstetric institutions in Azerbaijan]. Lab Delo (1991) 0.75
[Inhibition of transduction transmission of R-factors in E. coli by rifampicin]. Antibiotiki (1974) 0.75
[Effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine on the proliferation and differentiation of hematopoietic stem cells and erythropoiesis]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Physico-chemical and biological characteristics of Pseudomonas aeruginosa elastase]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Identification and serological typing of Pseudomonas aeruginosa by the indirect immunofluorescence method]. Zh Mikrobiol Epidemiol Immunobiol (1976) 0.75
[Biological characteristics of bacteria during the Cytos-2 Soviet-French space experiment]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Use of salts of quaternary ammonium base for creation of selective media for Pseudomonas aeruginosa]. Lab Delo (1976) 0.75
[Association of Candida albicans fungi with some opportunistic microorganisms in intestinal dysbiosis in patients of different age groups]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75
[Disappearance of penicillin resistance under the effect of acridine dyes and hydroxylamine in staphylococcal cultures]. Antibiotiki (1969) 0.75
[Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Ways of increasing the effectiveness of antibacterial drugs in the treatment of pseudomonas infection in burns]. Khirurgiia (Mosk) (1976) 0.75
[Change in sensitivity toward penicillin and penicillinase activity in cultures of Staphylococci after acquiring resistance toward ristomycin, sekazin and novobiocin in vitro]. Antibiotiki (1968) 0.75
[Elimination of drug resistance in E. coli and Sh. flexneri cultures with ethidium bromide]. Antibiotiki (1972) 0.75
[Possible use of plasmids for studying the effect of space flight factors on biological objects]. Antibiot Med Biotekhnol (1986) 0.75
[Elimination of R-factor in E. coli with acridine dyes and the action of UV rays]. Antibiotiki (1969) 0.75
[Use of genetic and molecular characteristics of R plasmids as an epidemiological marker in an outbreak of hospital infection]. Antibiotiki (1984) 0.75
[Development of a latex agglutination method for the diagnosis of Pseudomonas aeruginosa infection]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Pseudomonas aeruginosa exotoxin A and its role in the pathogenesis of pyocyaneus infection]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease. J Hyg Epidemiol Microbiol Immunol (1983) 0.75
[Comparative evaluation of the pathological process in a model of acute experimental pneumonia in rats caused by Pseudomonas aeruginosa strains of various origin]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. Akush Ginekol (Mosk) (1971) 0.75
[Conjugation transfer of plasmid resistance to gentamycin and other antibiotics in clinical strains of Ps. aeruginosa]. Antibiotiki (1977) 0.75
[Use of ionizing radiation for sterilizing alginate dressings containing various antibacterial preparations]. Antibiotiki (1981) 0.75
[Analysis of the associative relations of HLA-antigens with the intensity of production of certain antimicrobial antibodies]. Gematol Transfuziol (1988) 0.75
[Changes in the ultrastructure of hemolytic Streptococcus under the effect of penicillin and gramicidin C]. Antibiotiki (1970) 0.75
[Cloning and regulation of gene expression of EcoRV restriction- modification system]. Mol Biol (Mosk) (1990) 0.75
[Comparative study of dry selective nutrient media for isolating Pseudomonas aeruginosa from the environment]. Lab Delo (1982) 0.75
[Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims]. Khirurgiia (Mosk) (1980) 0.75
[Elimination of multiple drug resistance in Escherichia coli culture by aurantin and UV rays]. Antibiotiki (1970) 0.75
[Prevention of the development of drug resistant forms of staphylococci by a combination of antibiotics with DNA-tropic compounds]. Antibiotiki (1971) 0.75
[Treatment with ristomycin sulfate of pregnant rats infected with Staphylococci resistant to several antibiotics]. Antibiotiki (1971) 0.75
[Experimental development of aseptic adhesive films]. Antibiot Khimioter (1990) 0.75
[Protease activity of strains of Pseudomonas aeruginosa isolated from different sources]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Effect of R plasmids on the growth characteristics of Shigella sonnei and Escherichia coli]. Antibiot Med Biotekhnol (1985) 0.75
[Role of R-plasmids in the formation of hospital strains of conditionally-pathogenic gram-negative bacteria]. Antibiotiki (1983) 0.75
[Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Use of an immunoenzyme method for detecting specific antibodies to Pseudomonas aeruginosa in patients with acute and chronic lung diseases]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Microbiological and epidemiological aspects of infectious drug resistance in bacteria]. Zh Mikrobiol Epidemiol Immunobiol (1975) 0.75
[Infectious complications and hospital infection in the resuscitation and intensive therapy departments]. Khirurgiia (Mosk) (1986) 0.75
[The increase of resistance of Staphylococcus and Escherichia coli to some antibiotics and their combinations with DNA-tropic substances]. Antibiotiki (1970) 0.75
[The genetics of the antibiotics resistance of bacteria]. Antibiotiki (1974) 0.75
[Clinico-laboratory trials of a dry differential-diagnostic medium for nonenzymatic gram-negative bacteria]. Lab Delo (1988) 0.75
[Antistaphylococcal activity of the complex of natural cytokines]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.75
[Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. Akush Ginekol (Mosk) (1971) 0.75
[Isolation and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. An evaluation of the biological properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[A nutrient medium for the isolation and cultivation of Campylobacter]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[Conjugational transfer of R factor RP1 in Ps. aeruginosa and the possibility of inhibiting this process with a series of substances]. Antibiotiki (1976) 0.75
[Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin]. Antibiotiki (1983) 0.75
[Postoperative Proteus wound infection in patients with lactational purulent mastitis]. Akush Ginekol (Mosk) (1977) 0.75
[Action of various surface-active substances on the genetic transmission of R-plasmids in E. coli]. Antibiotiki (1977) 0.75
[Hospital infection due to Pseudomonas aeruginosa in resuscitation departments]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Dry medium with ampholan for isolation of Proteus and Providencia]. Lab Delo (1978) 0.75
[Search for antimicrobial agents and their various combinations that are effective in relation to the main microfloral representatives in the burn wound]. Antibiotiki (1980) 0.75
[Pyocin typing of Pseudomonas aeruginosa strains]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Effect of the action of nalidixic acid on the submicroscoic structure of bacteria]. Antibiotiki (1968) 0.75
[Antigenic complexes of Pseudomonas aeruginosa slime: their isolation and biological properties]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Effect of ethidium bromide on transference of R-factors in E. coli during conjugation]. Antibiotiki (1973) 0.75
[Possible dependence of the results of phage typing Ps. aeruginosa strains on the presence of R plasmids]. Antibiotiki (1983) 0.75
[Changes of Staphylococcus ultrastructure under the action of antibiotics of the penicillin group and 6-aminopenicillanic acid]. Mikrobiologiia (1969) 0.75
[New DNA modification-restriction plasmid system detected in a clinical strain of Escherichia coli]. Dokl Akad Nauk SSSR (1980) 0.75
[Infectious drug resistance of enterobacteria]. Antibiotiki (1970) 0.75
[Immunoenzyme method of determining Pseudomonas aeruginosa exotoxin A by using a conjugate of beta-lactamase with specific antibodies]. Antibiot Med Biotekhnol (1987) 0.75
[The assessment of the toxigenicity of clinical strains of Pseudomonas aeruginosa by an immunoenzyme method using nitrocellulose filters]. Zh Mikrobiol Epidemiol Immunobiol (1990) 0.75
[Production and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. IV. The effect of immunization with Pseudomonas aeruginosa vaccine on the immune status of volunteer donors]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Comparative study of the antibacterial activity of a number of new antibiotics and their combinations in relation to Pseudomonas aeruginosa]. Antibiotiki (1979) 0.75
[The therapeutic use of diucifon-activated immunocytes in adoptive transfer in mice with burn trauma complicated by Pseudomonas aeruginosa infection]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75
[Role of Pseudomonas aeruginosa in the etiology of postoperative suppurative inflammatory complications in patients with chronic suppurative lung diseases]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Study of the immune antibody spectrum in blood and plasma donors]. Gematol Transfuziol (1987) 0.75
[Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Development of a polyvalent erythrocyte diagnostic agent based on the antigens of Pseudomonas aeruginosa slime]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.75
[Isolation and primary characteristics of elastase from a clinical strain of Pseudomonas aeruginosa]. Zh Mikrobiol Epidemiol Immunobiol (1988) 0.75
[Ethidium bromide inhibition of R-factor transduction in E. coli J 5-3 R1 drd withphage Plkc]. Antibiotiki (1973) 0.75
[Microbiocenosis of oral cavity in patients from different age groups]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.75
[Effectiveness of a polyvalent corpuscular Pseudomonas aeruginosa vaccine, antibiotics and their combinations in experimental chronic Pseudomonas aeruginosa infection]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Possible mechanisms of the rifampicin suppression of the conjugation transfer of R-factors in Escherichia coli]. Antibiotiki (1975) 0.75
[Method for detection of transmissive R-factors in Enterobacteriaceae by using replicating stamp]. Antibiotiki (1972) 0.75